From deep-vein arterialization to a 3D stent, data presented at VIVA 2021 encourage novel thinking about peripheral vascular management.
New technologies that divert or improve blood flow offer promising options for patients with chronic limb-threatening ischemia (CLTI), according to two presentations this week at VIVA 2021 … We know there are a group of these patients who are nonrevascularizable with standard means, either percutaneous angioplasty or surgical bypass, and it’s in this group of patients where we’d like to divert the blood flow into the venous system to try and deliver that oxygenated blood to the foot and allow their wounds to heal,” noted Daniel Clair, MD (Vanderbilt University Medical Center, Nashville, TN) … read more